Indicative Announcement on the Company Being Subject to Compulsory Enforcement
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Indicative Announcement on the Company Being Subject to Compulsory Enforcement
Filed with SSE · · 2 pages · Chinese
Release
Hainan Huluwa Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Hainan Huluwa Pharmaceutical
- Indicative Announcement on the Completion of Judicial Auction and Transfer of Some Shares Held by Controlling Shareholder and Equity Change
- Announcement on Confirming Remunerations for Directors and Senior Management Members in 2025 and 2026 Remuneration Plan
- Announcement on Freezing of Some Shares of Controlling Shareholder
- Announcement on Company Re-certified as High-tech Enterprise
- Announcement on Progress in Implementing Other Risk Warnings for the Company's Stocks
Later from Hainan Huluwa Pharmaceutical
- Announcement on Proposed Inclusion of Company Drugs in the Centralized Volume Procurement of National Chinese Patent Medicine Procurement Alliance (4th Round)
- Announcement on Judicial Freeze of Part of the Controlling Shareholder's Shares, Progress in Enforcement, and Execution of Settlement Agreement
- Announcement on Pledge of Partial Shares of Shareholder
- Announcement on Concurrent Implementation of Other Risk Warnings for the Company’s Shares
- Announcement on Resignation of Independent Director
Follow Hainan Huluwa Pharmaceutical into a list and get an email when it puts out news.
Follow Hainan Huluwa Pharmaceutical